Retatrutide Hit 30% Loss With No Plateau — The Recomp Implications
TRIUMPH-1 confirmed 28.3% average weight loss with no plateau at 104 weeks. Here's what the retatrutide data means for body recomposition.
TRIUMPH-1 confirmed 28.3% average weight loss with no plateau at 104 weeks. Here's what the retatrutide data means for body recomposition.
Elamipretide is the first longevity peptide to receive FDA approval. Here's what it means for mitochondrial performance and energy output.
Sauna triggers a 200-300% growth hormone spike. Here is how to stack peptides with heat stress for maximum hormetic adaptation.
Two of the most researched performance compounds. Here is what happens when you stack them.
Chronic cortisol destroys testosterone, sleep, muscle, and cognition. These peptides target the stress cascade at every level.
Cerebrolysin, Semax, and BPC-157 for post-concussion syndrome, blast injury, and the lingering brain damage nobody talks about.
BPC-157, TB-500, and targeted protocols for herniated discs, sciatica, spinal stenosis, and the chronic back pain that wrecks everything.
Sports injury-specific protocols for the connective tissue damage that sidelines athletes the longest.
Seven peptides face an FDA advisory vote on July 23-24. Here is what it means for your protocols, your supply chain, and your backup plan.
Circadian disruption damages every system. These peptides target the specific pathways that shift work destroys.
Which peptide. How to reconstitute. How to inject. What to expect week by week. Everything you need and nothing you do not.
Smoke inhalation, cardiac overload, shift-work destruction, and the peptide stack for men who run toward the fire.
GHK-Cu for better color retention. BPC-157 for faster wound closure. The aftercare protocol the tattoo community has not discovered yet.
The biological and psychological framework for men rebuilding from the injury that almost ended their athletic life.
How cold water immersion amplifies peptide signaling for recovery, inflammation control, and hormetic adaptation.
Semax, Selank, Cerebrolysin, and the nootropic peptide tier list for men who need sustained high-output cognition.
Gut adaptation, metabolic optimization, and the peptide stack for men eating meat and nothing else.
Trades, construction, and manual labor destroy your body in specific ways. Here is the targeted recovery stack.
BPC-157, thymosin alpha-1, and targeted peptides for BPH, inflammation, and monitoring PSA levels.
How to read your post-protocol labs, what markers to track, and when to get tested.
Brain-level desire (PT-141) vs blood flow mechanics (Viagra/Cialis). When to use each, when to combine, side effects, and the complete comparison table.
TB-500 cardiac repair, BPC-157 blood pressure modulation, and MOTS-C cardiometabolic protection. The #1 killer deserves more than aspirin.
How to layer peptides on top of TRT: CJC-1295/Ipa for GH, BPC-157/TB-500 for joints, MOTS-C for metabolism, DSIP for sleep. Bloodwork monitoring included.
SARMs suppress your HPTA. Peptides don’t. Complete comparison: safety, muscle, fat loss, liver, PCT requirements. Plus the SARM replacement stack.
GLP-1 agonists halve AHI scores. DSIP restores sleep architecture. The peptide approach to the 30 million men who stop breathing at night.
MOTS-C for hypoxic adaptation, BPC-157 for altitude gut dysfunction, and the peptide stack for hunters, hikers, and high-altitude operators.
Kisspeptin-10 for LH pulsing, NAD+ for sperm mitochondria. What to stop before conceiving (TRT, GLP-1s, SARMs, finasteride). Fertility-compatible peptides list.
When to take every peptide around your fasting window. CJC-1295/Ipa timing rules, MOTS-C fasted synergy, BPC-157 oral timing. Charts for 16:8, 20:4, OMAD.
GHK-Cu, BPC-157, and TB-500 for hair support without DHT suppression. The anti-finasteride hair protocol for men who refuse to compromise their androgens.
Kisspeptin-10 restarts LH pulsing. BPC-157 protects organs. NAD+ supports cellular recovery. DSIP fixes post-cycle sleep. The peptide-based PCT protocol.
BPC-157 for grappler joints, TB-500 for systemic recovery, Semax for neuroprotection, DSIP for recovery sleep. WADA considerations for competitors.
CJC-1295/Ipa for GH, Tesamorelin for visceral fat, MOTS-C for metabolism, BPC-157 for joints. The phased peptide protocol for men 40+.
BPC-157 for gut repair, liver protection, and the biological reality of what alcohol does to men who drink.
BPC-157 injection protocol for rotator cuff injuries: local vs systemic, dosing, the Wolverine Stack for shoulders, and when to pair with TB-500.
Why the research community combines these two peptides, what the theoretical basis is, and what the evidence actually supports about synergistic tissue repair.
BPC-157, Cerebrolysin, and the neuroprotective peptides targeting the cochlear damage that nobody thinks is fixable.
Thymosin Beta-4 fragment (TB-500) has been studied for tissue repair and wound healing. Here's what the research actually supports — and where it falls short.
Third-party testing, certificates of analysis, purity thresholds, and red flags. A practical framework for evaluating research peptide vendors.
In February 2026, the HHS Secretary announced 14 peptides would be 'unleashed.' Three months later, here's what's actually changed, what hasn't, and why the distinction matters.
A clear-eyed overview of where peptides stand legally in the United States — compounding eligibility, 'research use only' designations, DEA scheduling, and what's changing.
Sitting disease, lumbar degeneration, metabolic dysfunction, and the recovery protocol for men who live behind the wheel.
GHK-Cu reverses fibrosis. BPC-157 breaks down adhesions. The injuries you thought were permanent may not be.
KPV is a tripeptide fragment of alpha-MSH with documented anti-inflammatory properties in preclinical models. Here's what the research shows — and what the July 2026 PCAC meeting means for…
Pre-op preparation, post-op healing, and the phase-by-phase peptide protocol for orthopedic, abdominal, and dental surgery.
The two most widely used growth hormone-releasing peptides in the research community — how they work, what the evidence shows, and why the PCAC previously voted against them.
GHK-Cu is one of the most extensively studied peptides in regenerative medicine — with decades of research, topical FDA-cleared products, and ongoing review for injectable compounding.
Endurance athletes face unique recovery demands. These peptides target the specific damage patterns of long-distance training.
BPC-157 for periosteal repair, TB-500 for surrounding tissue, and the protocol for the fracture that will not heal on schedule.
Two decades of rodent data, a handful of early human studies, and a regulatory landscape in flux. Here's the evidence — and the gaps — for the most-discussed peptide in the recovery space.
The FDA's Pharmacy Compounding Advisory Committee meets July 23-24, 2026 to review BPC-157, TB-500, KPV, and MOTs-C. Here's what's at stake and what to expect.